{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:18:49Z","timestamp":1766269129381,"version":"build-2065373602"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,12]]},"DOI":"10.7759\/cureus.94426","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:55:32Z","timestamp":1760334932000},"source":"Crossref","is-referenced-by-count":1,"title":["Rocuronium-Induced Rhabdomyolysis: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Meidai","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoshuai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangmeng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2020.101015","article-title":"Rhabdomyolysis","volume":"66","author":"Cabral BM","year":"2020","unstructured":"Cabral BM, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. Dis Mon. 2020, 66:101015. 10.1016\/j.disamonth.2020.101015","journal-title":"Dis Mon"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000002674","article-title":"Interpretable machine learning model for early prediction of mortality in ICU patients with rhabdomyolysis","volume":"53","author":"Liu C","year":"2021","unstructured":"Liu C, Liu X, Mao Z, et al.. Interpretable machine learning model for early prediction of mortality in ICU patients with rhabdomyolysis. Med Sci Sports Exerc. 2021, 53:1826-34. 10.1249\/MSS.0000000000002674","journal-title":"Med Sci Sports Exerc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/000313481508101219","article-title":"Role of elevated aminotransferases in ICU patients with rhabdomyolysis","volume":"81","author":"Raurich JM","year":"2015","unstructured":"Raurich JM, Llompart-Pou JA, Rodr\u00edguez-Yago M, Ferreruela M, Royo C, Ayestar\u00e1n I. Role of elevated aminotransferases in ICU patients with rhabdomyolysis. Am Surg. 2015, 81:1209-15. 10.1177\/000313481508101219","journal-title":"Am Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-025-02964-9","article-title":"Rhabdomyolysis in intensive care unit-distinctive clinical indicators and prognosis","volume":"25","author":"Wang Z","year":"2025","unstructured":"Wang Z, Wang Q, Chen J, Cai L. Rhabdomyolysis in intensive care unit-distinctive clinical indicators and prognosis. BMC Anesthesiol. 2025, 25:84. 10.1186\/s12871-025-02964-9","journal-title":"BMC Anesthesiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0897190018795983","article-title":"Succinylcholine-induced rhabdomyolysis in adults: case report and review of the literature","volume":"33","author":"Barrons RW","year":"2020","unstructured":"Barrons RW, Nguyen LT. Succinylcholine-induced rhabdomyolysis in adults: case report and review of the literature. J Pharm Pract. 2020, 33:102-7. 10.1177\/0897190018795983","journal-title":"J Pharm Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.09.018","article-title":"Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: a historical review","volume":"37","author":"Wilcox SR","year":"2017","unstructured":"Wilcox SR. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: a historical review. J Crit Care. 2017, 37:149-55. 10.1016\/j.jcrc.2016.09.018","journal-title":"J Crit Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91471-4","article-title":"Severe myopathy after status asthmaticus","volume":"310","author":"Macfarlane IA","year":"1977","unstructured":"Macfarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet. 1977, 310:615. 10.1016\/S0140-6736(77)91471-4","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.12.183","article-title":"Steroid-induced crisis and rhabdomyolysis in a patient with pheochromocytoma: a case report and review","volume":"146","author":"Takahashi N","year":"2011","unstructured":"Takahashi N, Shimada T, Tanabe K, et al.. Steroid-induced crisis and rhabdomyolysis in a patient with pheochromocytoma: a case report and review. Int J Cardiol. 2011, 146:e41-5. 10.1016\/j.ijcard.2008.12.183","journal-title":"Int J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2011.0102","article-title":"Corticosteroids in the treatment of alcohol-induced rhabdomyolysis","volume":"86","author":"Antoon JW","year":"2011","unstructured":"Antoon JW, Chakraborti C. Corticosteroids in the treatment of alcohol-induced rhabdomyolysis. Mayo Clin Proc. 2011, 86:1005-7. 10.4065\/mcp.2011.0102","journal-title":"Mayo Clin Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/cc188","article-title":"Rapid and safe intubation with rocuronium bromide in critically ill patients","volume":"2","author":"Estecha M","year":"1998","unstructured":"Estecha M, Molina J, De la Cruz C, Ruiz Del Fresno L, Daga D, Garc\u00eda-Alc\u00e1ntara A, Carpintero J. Rapid and safe intubation with rocuronium bromide in critically ill patients. Crit Care. 1998, 2:P058. 10.1186\/cc188","journal-title":"Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3126\/ajms.v15i2.58850","article-title":"A comparative study to evaluate the optimum intubating dose of rocuronium bromide versus succinylcholine chloride as an ideal intubating muscle-relaxing agent","volume":"15","author":"Bhunia P","year":"2024","unstructured":"Bhunia P, Mandal A, Chatterjee S, Mayur N. A comparative study to evaluate the optimum intubating dose of rocuronium bromide versus succinylcholine chloride as an ideal intubating muscle-relaxing agent. Asian J Med Sci. 2024, 15:196-201. 10.3126\/ajms.v15i2.58850","journal-title":"Asian J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202411.1364.v1","article-title":"ICU-acquired weakness: from pathophysiology to management in critical care [PREPRINT]","volume":"2","author":"Petrucci M","year":"2025","unstructured":"Petrucci M, Gemma S, Carbone L, et al.. ICU-acquired weakness: from pathophysiology to management in critical care [PREPRINT]. Emerg Care Med. 2025, 2:4. 10.20944\/preprints202411.1364.v1","journal-title":"Emerg Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.06.006","article-title":"ICU-acquired weakness: a rehabilitation perspective of diagnosis, treatment, and functional management","volume":"150","author":"Zorowitz RD","year":"2016","unstructured":"Zorowitz RD. ICU-acquired weakness: a rehabilitation perspective of diagnosis, treatment, and functional management. Chest. 2016, 150:966-71. 10.1016\/j.chest.2016.06.006","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.05.036","article-title":"ICU-acquired weakness","volume":"39","author":"Ni F","year":"2020","unstructured":"Ni F, Zhou C, Zhang HL. ICU-acquired weakness. Clin Nutr. 2020, 39:2317-8. 10.1016\/j.clnu.2020.05.036","journal-title":"Clin Nutr"},{"key":"ref15","article-title":"Massive rhabdomyolysis due to corticosteroids and muscle blocking agents, proven by rechallenge","author":"Schouten VL","year":"2019","unstructured":"Schouten VL, van der Spoel JI. Massive rhabdomyolysis due to corticosteroids and muscle blocking agents, proven by rechallenge. Neth J Crit Care. 2019,","journal-title":"Neth J Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2165\/00128415-200912640-00059","article-title":"A case of rhabdomyolysis after general anesthesia using propofol, rocuronium bromide and sevoflurane","volume":"56","author":"Kaneko Y","year":"2009","unstructured":"Kaneko Y, Ichinohe T, Mamiya H, Matsuura Y, Kemmochi M, Otsubo Y. A case of rhabdomyolysis after general anesthesia using propofol, rocuronium bromide and sevoflurane. Anesth Prog. 2009, 56:107-8. 10.2165\/00128415-200912640-00059","journal-title":"Anesth Prog"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000280935.90260.d0","article-title":"Postoperative hyperthermia, rhabdomyolysis, critical temperature, and death in a former premature infant after his ninth general anesthetic","volume":"105","author":"Phadke A","year":"2007","unstructured":"Phadke A, Broadman LM, Brandom BW, Ozolek J, Davis PJ. Postoperative hyperthermia, rhabdomyolysis, critical temperature, and death in a former premature infant after his ninth general anesthetic. Anesth Analg. 2007, 105:977-80. 10.1213\/01.ane.0000280935.90260.d0","journal-title":"Anesth Analg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000260135.46070.c3","article-title":"A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block","volume":"104","author":"Groudine SB","year":"2007","unstructured":"Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007, 104:555-62. 10.1213\/01.ane.0000260135.46070.c3","journal-title":"Anesth Analg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12628","article-title":"Neuromuscular effects of rocuronium bromide in patients in statin therapy for at least three months","volume":"119","author":"Ren H","year":"2016","unstructured":"Ren H, Lv H. Neuromuscular effects of rocuronium bromide in patients in statin therapy for at least three months. Basic Clin Pharmacol Toxicol. 2016, 119:582-7. 10.1111\/bcpt.12628","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199402000-00021","article-title":"The effect of CO2-induced acid-base changes on the potencies of muscle relaxants and antagonism of neuromuscular block by neostigmine in rat in vitro","volume":"78","author":"Aziz L","year":"1994","unstructured":"Aziz L, Ono K, Ohta Y, Morita K, Hirakawa M. The effect of CO2-induced acid-base changes on the potencies of muscle relaxants and antagonism of neuromuscular block by neostigmine in rat in vitro. Anesth Analg. 1994, 78:322-7. 10.1213\/00000539-199402000-00021","journal-title":"Anesth Analg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-016-2235-9","article-title":"Effect of lung-protective ventilation-induced respiratory acidosis on the duration of neuromuscular blockade by rocuronium","volume":"30","author":"Taguchi S","year":"2016","unstructured":"Taguchi S, Ono K, Hidaka H, Koyama Y. Effect of lung-protective ventilation-induced respiratory acidosis on the duration of neuromuscular blockade by rocuronium. J Anesth. 2016, 30:994-8. 10.1007\/s00540-016-2235-9","journal-title":"J Anesth"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-59312-8_9","article-title":"Neuromuscular blocking agents","author":"Bignami E","year":"2018","unstructured":"Bignami E, Saglietti F. Neuromuscular blocking agents. Critical Care Sedation. De Gaudio AR, Romagnoli S (ed): Springer, Cham, 2018. 10.1007\/978-3-319-59312-8_9"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/anr3.12060","article-title":"Rocuronium priming for tracheal intubation in COVID-19 patients","volume":"8","author":"Hoshijima H","year":"2020","unstructured":"Hoshijima H, Nagasaka H, Ozaki M, Komiyama K, Mieda T, Nakamura C, Doi K. Rocuronium priming for tracheal intubation in COVID-19 patients. Anaesth Rep. 2020, 8:98-100. 10.1002\/anr3.12060","journal-title":"Anaesth Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00455-2","article-title":"Neuromuscular blockade management in the critically Ill patient","volume":"8","author":"Renew JR","year":"2020","unstructured":"Renew JR, Ratzlaff R, Hernandez-Torres V, Brull SJ, Prielipp RC. Neuromuscular blockade management in the critically Ill patient. J Intensive Care. 2020, 8:37. 10.1186\/s40560-020-00455-2","journal-title":"J Intensive Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404472-rocuronium-induced-rhabdomyolysis-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:55:34Z","timestamp":1760334934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404472-rocuronium-induced-rhabdomyolysis-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,12]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.94426","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,12]]}}}